Antagonism of Epidermal Growth Factor Receptor Tyrosine Kina…

Established


19
Citations
33
Refs
2005
Year
Search Works
Work Details
  • DOI 10.1159/000084909
  • PMID https://pubmed.ncbi.nlm.nih.gov/15897684
  • OpenAlex ID W2045105604
  • Type Article
  • Language EN
  • Published 01 Jan 2005
  • Volume 18 (3)
  • Pages 123–131
  • Source Skin Pharmacology and Physiology
  • Publisher Karger Publishers
  • FWCI 1.17
  • Countries 1
  • Institutions 2
  • Added 24 Jun 2016
  • Updated 16 Oct 2026
MENU
0

Antagonism of Epidermal Growth Factor Receptor Tyrosine Kinase Ameliorates the Psoriatic Phenotype in Organ-Cultured Skin

Article 2005 EN

Psoriatic plaque skin incubated for eight days in organ culture in the presence of a potent epidermal growth factor (EGF) receptor tyrosine kinase (RTK) antagonist reverted to a more normal histological appearance, while untreated psoriatic plaque skin retained histological features associated with the psoriatic phenotype. In concomitant studies it was shown that the EGF-RTK antagonist had no sign…

19

Citations

33

References

4

Authors

1.17

FWCI

Citations by Year
Last 5 years
Topics
Keywords
UN Sustainable Development Goals
1 SDGs
Authors & Affiliations
4 authors
#AuthorInstitutionsORCID
1 James Varani University of Michigan (US) Michigan Medicine (US) —
2 Hayder F. Lateef — —
3 Kevin S. Fay — —
4 James T. Elder University of Michigan (US) Michigan Medicine (US)

Data: OpenAlex